187 related articles for article (PubMed ID: 35488350)
21. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
Li X; Li X; Hu Y; Liu O; Wang Y; Li S; Yang Q; Lin B
BMC Cancer; 2023 Jun; 23(1):573. PubMed ID: 37349676
[TBL] [Abstract][Full Text] [Related]
22. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
Chen C; Wang X; Huang S; Wang L; Han L; Yu S
Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
[TBL] [Abstract][Full Text] [Related]
23. Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer.
Zhou Q; Hou CN; Yang HJ; He Z; Zuo MZ
Cancer Manag Res; 2018; 10():6937-6948. PubMed ID: 30588099
[TBL] [Abstract][Full Text] [Related]
24. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
25. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
[TBL] [Abstract][Full Text] [Related]
26. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
[TBL] [Abstract][Full Text] [Related]
27. GATA-related hematologic disorders.
Shimizu R; Yamamoto M
Exp Hematol; 2016 Aug; 44(8):696-705. PubMed ID: 27235756
[TBL] [Abstract][Full Text] [Related]
28. Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma.
Xu M; Jin T; Chen L; Zhang X; Zhu G; Wang Q; Lin Z
Gene; 2019 May; 696():63-71. PubMed ID: 30776464
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer.
Sun X; Wang S; Li Q
Front Genet; 2019; 10():879. PubMed ID: 31572453
[TBL] [Abstract][Full Text] [Related]
30. Microfibril Associated Protein 5 (MFAP5) Is Related to Survival of Ovarian Cancer Patients but Not Useful as a Prognostic Biomarker.
Kujawa KA; Zembala-Nożynska E; Syrkis JP; Cortez AJ; Kupryjańczyk J; Lisowska KM
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555638
[TBL] [Abstract][Full Text] [Related]
31.
Zhou Q; Zhang F; He Z; Zuo MZ
Front Oncol; 2019; 9():161. PubMed ID: 30967995
[No Abstract] [Full Text] [Related]
32. The prognostic values of the peroxiredoxins family in ovarian cancer.
Li S; Hu X; Ye M; Zhu X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30104402
[No Abstract] [Full Text] [Related]
33. Dynamic regulation of Gata factor levels is more important than their identity.
Ferreira R; Wai A; Shimizu R; Gillemans N; Rottier R; von Lindern M; Ohneda K; Grosveld F; Yamamoto M; Philipsen S
Blood; 2007 Jun; 109(12):5481-90. PubMed ID: 17327407
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.
Zhang P; Su T; Zhang S
J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer.
Zhu H; Yue H; Xie Y; Du Q; Chen B; Zhou Y; Liu W
Transl Cancer Res; 2021 Mar; 10(3):1537-1548. PubMed ID: 35116478
[TBL] [Abstract][Full Text] [Related]
36. Prognostic values of S100 family members in ovarian cancer patients.
Bai Y; Li LD; Li J; Lu X
BMC Cancer; 2018 Dec; 18(1):1256. PubMed ID: 30558666
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of Tweety homologue 3 predicts poor clinical outcomes in ovarian cancer.
Zhou J; Xu Y; Chen X; Chen F; Zhang J; Zhu X
J Cancer; 2021; 12(23):7147-7157. PubMed ID: 34729116
[No Abstract] [Full Text] [Related]
38. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.
Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
[TBL] [Abstract][Full Text] [Related]
39. Characterization of hematopoietic GATA transcription factor expression in mouse and human dendritic cells.
Scheenstra MR; Salunkhe V; De Cuyper IM; Hoogenboezem M; Li E; Kuijpers TW; van den Berg TK; Gutiérrez L
Blood Cells Mol Dis; 2015 Dec; 55(4):293-303. PubMed ID: 26460250
[TBL] [Abstract][Full Text] [Related]
40. Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma.
Peters I; Dubrowinskaja N; Tezval H; Kramer MW; von Klot CA; Hennenlotter J; Stenzl A; Scherer R; Kuczyk MA; Serth J
Target Oncol; 2015 Jun; 10(2):267-75. PubMed ID: 25230694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
